Would they be re-ordering if they didn't think CardioCel was the best available technology at their disposal? No, of course not…. considering Admedus are targeting the top centres in The US and The EU you couldn't get a better endorsement of the technology than having these centres re-ordering the patch after having trialled it for themselves. The writing is on the wall yet some remain determined not to open their eyes…. AHZ is set to begin a run of quarter after quarter growth for possibly the next decade.
Would they be re-ordering if they didn't think CardioCel was the...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |